1
/
of
1
Cambridge University Press
Recreational Drugs Repurposed for Medicinal Use
Recreational Drugs Repurposed for Medicinal Use
💎 Earn 254 Points (£2.54) on this item.
Low Stock: Only 2 copies remaining
Regular price
£50.80 GBP
Regular price
Sale price
£50.80 GBP
Unit price
/
per
Taxes included.
Shipping calculated at checkout.
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £3.89. Subject to product weight & dimension
Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.
Couldn't load pickup availability
- More about Recreational Drugs Repurposed for Medicinal Use
Recreational drugs that were once proscribed are now being explored as new pharmacotherapies. This topical book provides a balanced guide to new and far-reaching changes in our health system and our drug laws. Written by leading scientists, practitioners and researchers, it examines the evidence, discusses the history and context, and describes the pharmacology of recreational drugs that are being repurposed as medical treatments as well as recreational drugs that are currently being investigated. Amongst the drugs covered are psilocybin, cannabis, ketamine, MDMA, amphetamine and methylphenidate. Where known, the mechanisms of action, pharmacokinetics, putative indications, and safety and tolerability are described for each agent. Drugs used by indigenous communities for ritual purposes, currently being considered for treatment by the mainstream medical establishment, are also investigated. This is an up-to-date evidence-based resource for all people interested in the medical use of recreational drugs.
- Publication date: 31 August 2026
- Page count: 192
- Publisher: Cambridge University Press
- Format: Paperback
- ISBN-13: 9781009585347
UK and International shipping information
UK and International shipping information
We deliver throughout the United Kingdom and to 128 countries and territories worldwide, including the United States, Australia, Canada, Germany, Spain and France.
